Ingalls & Snyder LLC’s Idexx Laboratories IDXX Stock Holding History

Ingalls & Snyder LLC’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$244K	Hold	435	–	–	0.01%	394
2025 Q4	$294K	Hold	435	–	–	0.01%	373
2025 Q3	$278K	Hold	435	–	–	0.01%	398
2025 Q2	$233K	Sell	435 -100	-19%	-$47.8K	0.01%	406
2025 Q1	$225K	Buy	535 +5	+0.9%	+$2.17K	0.01%	397
2024 Q4	$219K	Hold	530	–	–	0.01%	395
2024 Q3	$268K	Hold	530	–	–	0.01%	382
2024 Q2	$258K	Hold	530	–	–	0.01%	361
2024 Q1	$286K	Hold	530	–	–	0.01%	355
2023 Q4	$294K	Hold	530	–	–	0.01%	352
2023 Q3	$232K	Hold	530	–	–	0.01%	381
2023 Q2	$266K	Buy	530 +50	+10%	+$24K	0.01%	368
2023 Q1	$240K	Buy	+480	New	+$230K	0.01%	375
2022 Q2	–	Sell	-508	Closed	-$278K	–	458
2022 Q1	$278K	Hold	508	–	–	0.01%	386
2021 Q4	$334K	Hold	508	–	–	0.02%	363
2021 Q3	$316K	Hold	508	–	–	0.01%	375
2021 Q2	$321K	Hold	508	–	–	0.01%	375
2021 Q1	$249K	Buy	508 +2	+0.4%	+$1K	0.01%	389
2020 Q4	$253K	Buy	+506	New	+$226K	0.01%	373
2020 Q3	–	Sell	-806	Closed	-$266K	–	406
2020 Q2	$266K	Buy	+806	New	+$233K	0.02%	332
2020 Q1	–	Sell	-841	Closed	-$220K	–	422
2019 Q4	$220K	Sell	841 -2	-0.2%	-$527	0.01%	362
2019 Q3	$229K	Buy	+843	New	+$235K	0.01%	381

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ingalls & Snyder LLC's IDXX Position: Q1 2026 in Review

Ingalls & Snyder LLC held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 435 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #394.

Ingalls & Snyder LLC first reported a position in IDXX in Q3 2019 and has held it in 22 quarters since. The position peaked at $334K in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Ingalls & Snyder LLC held 435 shares of Idexx Laboratories worth $244K as of Q1 2026.
Ingalls & Snyder LLC left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up 0.01% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #394 holding.
Ingalls & Snyder LLC first reported a position in Idexx Laboratories in Q3 2019 and has held it in 22 quarters since.
Ingalls & Snyder LLC's Idexx Laboratories position peaked at $334K in Q4 2021.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.